Ribavirin-13C5

• Target :

  HCV Protease|||RSV|||Antibiotic

• Related Pathways :

  Microbiology/Virology|||Proteases/Proteasome

• Bioactivity :

  Ribavirin-13C5is intended for use as an internal standard for the quantification of ribavirin by GC- or LC-MS. Ribavirin is an antiviral guanosine nucleoside analog.1,2Upon entry into cells, ribavirin is metabolized to an active triphosphate form that induces viral RNA chain termination and inhibits viral polymerases. It reduces replication in a panel of seven RNA and four DNA viruses in Vero cells (EC50s = 2-95 ?g/ml) .3Ribavirin also reduces replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Vero cells (EC50= 109.5 ?M) .4Aerosol administration of ribavirin (30 mg/kg) reduces mortality in a mouse model of influenza A infection.5Formulations containing ribavirin have been used in the treatment of respiratory syncytial virus (RSV), hepatitis C virus (HCV), and viral hemorrhagic fevers.

• Smiles :

  NC(=O)c1ncn(n1)[13C@@H]1O[13C@H]([13CH2]O)[13C@@H](O)[13C@H]1O

• Molecular Formula :

  C8H12N4O5

• Molecular Weight :

  249.17

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1646818-35-0